| breast cancer - adjuvant | breast cancer - triple negative | ||||
| breast cancer - adjuvant | es-BC - TNBC - NA - all population | mBC - TNBC - L1 - all population | mBC-Triple negative (TNBC) - 2nd Line (L2) | mBC - TNBC - L2 - all population | |
| poly ADP-ribose polymerase (PARP) inhibitor | |||||
| olaparib | |||||
| talazoparib | |||||
| veliparib plus paclitaxel plus carboplatin | |||||